Clinical Trial Update: XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of rivaroxaban for pulmonary embolism managed with catheter-directed thrombolysis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Susan Smyth | Conditions: Pulmonary Embolism, Venous Thrombosis | Phase 4 | Status: TERMINATED | Results posted: 2018-09-27